T 2005, 20(9):1874?879. Kamgar M, Zaldivar F, Vaziri ND, Pahl MV: Antioxidant therapy will not ameliorate oxidative tension and inflammation in patients with end-stage renal illness. J Natl Med Assoc 2009, 101(four):336?44. Kasai H: Analysis of a kind of oxidative DNA damage, 8-hydroxy-2deoxyguanosine, as a marker of cellular oxidative tension during carcinogenesis. Mutat Res 1997, 387(three). Zhang K, Dong J, Cheng X, Bai W, Guo W, Wu L, Zuo L: Association among vitamin C deficiency and dialysis modalities. Nephrology (Carlton) 2012, 17(5):452?57. Reuler JB, Broudy VC, Cooney TG: Adult scurvy. JAMA 1985, 253(six):805?07. Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ: Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis individuals. Nephrol Dial Transplant 2008, 23(six):2058?063. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS: Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995, 41(eight Pt 1):1135?138. Alkhunaizi AM, Chan L: Secondary oxalosis: a reason for delayed recovery of renal function inside the setting of acute renal failure. J Am Soc Nephrol 1996, 7(11):2320?326. Durose CL, Holdsworth M, Watson V, Przygrodzka F: Knowledge of dietary restrictions and the healthcare consequences of noncompliance by individuals on hemodialysis usually are not predictive of dietary compliance. J Am Diet Assoc 2004, 104(1):35?1. Boeschoten EW, Schrijver J, Krediet RT, Schreurs WH, Arisz L: Deficiencies of vitamins in CAPD individuals: the effect of supplementation. Nephrol Dial Transplant 1988, three(two):187?93. Wang S, Schram IM, Sund RB: Determination of plasma ascorbic acid by HPLC: technique and stability research. Eur J Pharm Sci 1995, three(4):231?39. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele DSC: Implication of an enhanced oxidative pressure in the25.26.27. 28.29.30.31.32.33.34.35.36. 37.formation of advanced glycation finish goods in sufferers with end-stage renal failure. Kidney Int 1997, 51(four):1170?181. Bellocq A, Suberville S, Philippe C, Bertrand F, Perez J, Fouqueray B, Cherqui G, Baud L: Low environmental pH is accountable for the induction of nitric-oxide synthase in macrophages.Price of 194924-95-3 Proof for involvement of nuclear factor-kappaB activation.150529-93-4 Order J Biol Chem 1998, 273(9):5086?092.PMID:33459187 Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A, Ok E, Ozkahya M: Relations in between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance evaluation in peritoneal dialysis sufferers. Nephrol Dial Transplant 2011, 26(five):1708?716. Stenvinkel P, Alvestrand A: Inflammation in end-stage renal illness: sources, consequences, and therapy. Semin Dial 2002, 15(five):329?37. Tarng DC, Liu TY, Huang TP: Protective impact of vitamin C on 8-hydroxy2-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis individuals. Kidney Int 2004, 66(two):820?31. Finkelstein FO, Juergensen P, Wang S, Santacroce S, Levine M, Kotanko P, Levin NW, Handelman GJ: Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Perit Dial Int 2011, 31(1):74?9. Lee EJ, Myint CC, Tay ME, Yusuf N, Ong CN: Serum ascorbic acid and protein calorie malnutrition in continuous ambulatory peritoneal dialysis sufferers. Adv Perit Dial 2001, 17:219?22. Attallah N, Osman-Malik Y, Frinak S, Besarab A: Effect of intravenous ascorbic acid in hemodialysis sufferers with EPO-hyporesponsive anemia and hyperferritine.